Nampa Dialysis Center in Nampa, Idaho - Dialysis Center

Nampa Dialysis Center is a medicare approved dialysis facility center in Nampa, Idaho and it has 15 dialysis stations. It is located in Canyon county at 846 Parkcentre Way, Nampa, ID, 83651. You can reach out to the office of Nampa Dialysis Center at (208) 467-5180. This dialysis clinic is managed and/or owned by Davita. Nampa Dialysis Center has the following ownership type - Profit. It was first certified by medicare in October, 1989. The medicare id for this facility is 132501 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameNampa Dialysis Center
Location846 Parkcentre Way, Nampa, Idaho
No. of Dialysis Stations 15
Medicare ID132501
Managed ByDavita
Ownership TypeProfit
Late Shifts No

Contact Information


846 Parkcentre Way, Nampa, Idaho, 83651
(208) 467-5180

News Archive

Study to assess voluntary HIV testing, prompt treatment in South Africa, Zambia

A study in South Africa and Zambia will assess whether house-to-house voluntary HIV testing and prompt treatment of HIV infection, along with other proven HIV prevention measures, can substantially reduce the number of new HIV infections across communities.

Two immunotherapy approaches for multiple myeloma show hope

Researchers from the University of Pennsylvania's Abramson Cancer Center have developed two experimental immunotherapy methods that include one chimeric antigen receptor (CAR) T cell therapy for the treatment of multiple myeloma patients who were not responding to other treatments.

Paralympic athlete Amy Purdy to deliver opening keynote address at 41st ARN Annual Educational Conference

Registration is open for the 41st Association of Rehabilitation Nurses Annual Educational Conference on September 30-October 3, 2015, in New Orleans, which provides a forum for knowledge sharing and engagement that features the finest educators and thought leaders in the world of rehabilitation nursing.

Second Sight Medical Products receives FDA approval for Argus II Retinal Prosthesis System

The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP).

Combination of anti-Nodal and DTIC therapy can produce anti-cancer effects

Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.

Read more Medical News

› Verified 6 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Nampa Dialysis Center from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1225089915
Organization NameNampa Dialysis Center
Doing Business AsTotal Renal Care Inc
Address846 Parkcentre Way Nampa, Idaho, 83651
Phone Number(208) 467-5180

News Archive

Study to assess voluntary HIV testing, prompt treatment in South Africa, Zambia

A study in South Africa and Zambia will assess whether house-to-house voluntary HIV testing and prompt treatment of HIV infection, along with other proven HIV prevention measures, can substantially reduce the number of new HIV infections across communities.

Two immunotherapy approaches for multiple myeloma show hope

Researchers from the University of Pennsylvania's Abramson Cancer Center have developed two experimental immunotherapy methods that include one chimeric antigen receptor (CAR) T cell therapy for the treatment of multiple myeloma patients who were not responding to other treatments.

Paralympic athlete Amy Purdy to deliver opening keynote address at 41st ARN Annual Educational Conference

Registration is open for the 41st Association of Rehabilitation Nurses Annual Educational Conference on September 30-October 3, 2015, in New Orleans, which provides a forum for knowledge sharing and engagement that features the finest educators and thought leaders in the world of rehabilitation nursing.

Second Sight Medical Products receives FDA approval for Argus II Retinal Prosthesis System

The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP).

Combination of anti-Nodal and DTIC therapy can produce anti-cancer effects

Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.

Read more Medical News

› Verified 6 days ago


NPI Number1992796171
Doing Business AsSaint Alphonsus Nephrology Center
Address846 Parkcenter Way Nampa, Idaho, 83651
Phone Number(208) 467-5180

News Archive

Study to assess voluntary HIV testing, prompt treatment in South Africa, Zambia

A study in South Africa and Zambia will assess whether house-to-house voluntary HIV testing and prompt treatment of HIV infection, along with other proven HIV prevention measures, can substantially reduce the number of new HIV infections across communities.

Two immunotherapy approaches for multiple myeloma show hope

Researchers from the University of Pennsylvania's Abramson Cancer Center have developed two experimental immunotherapy methods that include one chimeric antigen receptor (CAR) T cell therapy for the treatment of multiple myeloma patients who were not responding to other treatments.

Paralympic athlete Amy Purdy to deliver opening keynote address at 41st ARN Annual Educational Conference

Registration is open for the 41st Association of Rehabilitation Nurses Annual Educational Conference on September 30-October 3, 2015, in New Orleans, which provides a forum for knowledge sharing and engagement that features the finest educators and thought leaders in the world of rehabilitation nursing.

Second Sight Medical Products receives FDA approval for Argus II Retinal Prosthesis System

The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP).

Combination of anti-Nodal and DTIC therapy can produce anti-cancer effects

Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.

Read more Medical News

› Verified 6 days ago


Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data25
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL12

News Archive

Study to assess voluntary HIV testing, prompt treatment in South Africa, Zambia

A study in South Africa and Zambia will assess whether house-to-house voluntary HIV testing and prompt treatment of HIV infection, along with other proven HIV prevention measures, can substantially reduce the number of new HIV infections across communities.

Two immunotherapy approaches for multiple myeloma show hope

Researchers from the University of Pennsylvania's Abramson Cancer Center have developed two experimental immunotherapy methods that include one chimeric antigen receptor (CAR) T cell therapy for the treatment of multiple myeloma patients who were not responding to other treatments.

Paralympic athlete Amy Purdy to deliver opening keynote address at 41st ARN Annual Educational Conference

Registration is open for the 41st Association of Rehabilitation Nurses Annual Educational Conference on September 30-October 3, 2015, in New Orleans, which provides a forum for knowledge sharing and engagement that features the finest educators and thought leaders in the world of rehabilitation nursing.

Second Sight Medical Products receives FDA approval for Argus II Retinal Prosthesis System

The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP).

Combination of anti-Nodal and DTIC therapy can produce anti-cancer effects

Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.

Read more Medical News

› Verified 6 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center51
    Adult patient months included in Kt/V greater than or equal to 1.2388
    Percentage of adult patients getting regular hemodialysis at the center99
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    Study to assess voluntary HIV testing, prompt treatment in South Africa, Zambia

    A study in South Africa and Zambia will assess whether house-to-house voluntary HIV testing and prompt treatment of HIV infection, along with other proven HIV prevention measures, can substantially reduce the number of new HIV infections across communities.

    Two immunotherapy approaches for multiple myeloma show hope

    Researchers from the University of Pennsylvania's Abramson Cancer Center have developed two experimental immunotherapy methods that include one chimeric antigen receptor (CAR) T cell therapy for the treatment of multiple myeloma patients who were not responding to other treatments.

    Paralympic athlete Amy Purdy to deliver opening keynote address at 41st ARN Annual Educational Conference

    Registration is open for the 41st Association of Rehabilitation Nurses Annual Educational Conference on September 30-October 3, 2015, in New Orleans, which provides a forum for knowledge sharing and engagement that features the finest educators and thought leaders in the world of rehabilitation nursing.

    Second Sight Medical Products receives FDA approval for Argus II Retinal Prosthesis System

    The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP).

    Combination of anti-Nodal and DTIC therapy can produce anti-cancer effects

    Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.

    Read more Medical News

    › Verified 6 days ago

  • Peritoneal Dialysis
    Adult patients getting regular peritoneal dialysis at the center23
    Adult patient months included in Kt/V greater than or equal to 1.7200
    Percentage of adult patients getting regular peritoneal dialysis at the center97
    Percentage of pediatric patients getting regular peritoneal dialysis at the center

    News Archive

    Study to assess voluntary HIV testing, prompt treatment in South Africa, Zambia

    A study in South Africa and Zambia will assess whether house-to-house voluntary HIV testing and prompt treatment of HIV infection, along with other proven HIV prevention measures, can substantially reduce the number of new HIV infections across communities.

    Two immunotherapy approaches for multiple myeloma show hope

    Researchers from the University of Pennsylvania's Abramson Cancer Center have developed two experimental immunotherapy methods that include one chimeric antigen receptor (CAR) T cell therapy for the treatment of multiple myeloma patients who were not responding to other treatments.

    Paralympic athlete Amy Purdy to deliver opening keynote address at 41st ARN Annual Educational Conference

    Registration is open for the 41st Association of Rehabilitation Nurses Annual Educational Conference on September 30-October 3, 2015, in New Orleans, which provides a forum for knowledge sharing and engagement that features the finest educators and thought leaders in the world of rehabilitation nursing.

    Second Sight Medical Products receives FDA approval for Argus II Retinal Prosthesis System

    The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP).

    Combination of anti-Nodal and DTIC therapy can produce anti-cancer effects

    Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.

    Read more Medical News

    › Verified 6 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Nampa Dialysis Center with elevated calcium levels.

Patients with hypercalcemia71
Hypercalcemia patient months603
Patients with Serumphosphor71
Patients with Serumphosphor less than 3.5 mg/dL10
Patients with Serumphosphor from 3.5 to 4.5 mg/dL24
Patients with Serumphosphor from 4.6 to 5.5 mg/dL31
Patients with Serumphosphor from 5.6 to 7 mg/dL20
Patients with Serumphosphor greater than 7 mg/dL15

News Archive

Study to assess voluntary HIV testing, prompt treatment in South Africa, Zambia

A study in South Africa and Zambia will assess whether house-to-house voluntary HIV testing and prompt treatment of HIV infection, along with other proven HIV prevention measures, can substantially reduce the number of new HIV infections across communities.

Two immunotherapy approaches for multiple myeloma show hope

Researchers from the University of Pennsylvania's Abramson Cancer Center have developed two experimental immunotherapy methods that include one chimeric antigen receptor (CAR) T cell therapy for the treatment of multiple myeloma patients who were not responding to other treatments.

Paralympic athlete Amy Purdy to deliver opening keynote address at 41st ARN Annual Educational Conference

Registration is open for the 41st Association of Rehabilitation Nurses Annual Educational Conference on September 30-October 3, 2015, in New Orleans, which provides a forum for knowledge sharing and engagement that features the finest educators and thought leaders in the world of rehabilitation nursing.

Second Sight Medical Products receives FDA approval for Argus II Retinal Prosthesis System

The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP).

Combination of anti-Nodal and DTIC therapy can produce anti-cancer effects

Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.

Read more Medical News

› Verified 6 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 49
Patient months included in arterial venous fistula and catheter summaries 270
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment76
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer5

News Archive

Study to assess voluntary HIV testing, prompt treatment in South Africa, Zambia

A study in South Africa and Zambia will assess whether house-to-house voluntary HIV testing and prompt treatment of HIV infection, along with other proven HIV prevention measures, can substantially reduce the number of new HIV infections across communities.

Two immunotherapy approaches for multiple myeloma show hope

Researchers from the University of Pennsylvania's Abramson Cancer Center have developed two experimental immunotherapy methods that include one chimeric antigen receptor (CAR) T cell therapy for the treatment of multiple myeloma patients who were not responding to other treatments.

Paralympic athlete Amy Purdy to deliver opening keynote address at 41st ARN Annual Educational Conference

Registration is open for the 41st Association of Rehabilitation Nurses Annual Educational Conference on September 30-October 3, 2015, in New Orleans, which provides a forum for knowledge sharing and engagement that features the finest educators and thought leaders in the world of rehabilitation nursing.

Second Sight Medical Products receives FDA approval for Argus II Retinal Prosthesis System

The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP).

Combination of anti-Nodal and DTIC therapy can produce anti-cancer effects

Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.

Read more Medical News

› Verified 6 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary60
Hospitalization Rate in facility168.1 (As Expected)
Hospitalization Rate: Upper Confidence Limit305.2
Hospitalization Rate: Lower Confidence Limit96.5

News Archive

Study to assess voluntary HIV testing, prompt treatment in South Africa, Zambia

A study in South Africa and Zambia will assess whether house-to-house voluntary HIV testing and prompt treatment of HIV infection, along with other proven HIV prevention measures, can substantially reduce the number of new HIV infections across communities.

Two immunotherapy approaches for multiple myeloma show hope

Researchers from the University of Pennsylvania's Abramson Cancer Center have developed two experimental immunotherapy methods that include one chimeric antigen receptor (CAR) T cell therapy for the treatment of multiple myeloma patients who were not responding to other treatments.

Paralympic athlete Amy Purdy to deliver opening keynote address at 41st ARN Annual Educational Conference

Registration is open for the 41st Association of Rehabilitation Nurses Annual Educational Conference on September 30-October 3, 2015, in New Orleans, which provides a forum for knowledge sharing and engagement that features the finest educators and thought leaders in the world of rehabilitation nursing.

Second Sight Medical Products receives FDA approval for Argus II Retinal Prosthesis System

The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP).

Combination of anti-Nodal and DTIC therapy can produce anti-cancer effects

Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.

Read more Medical News

› Verified 6 days ago

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at Nampa Dialysis Center were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility30.3 (As Expected)
Readmission Rate: Upper Confidence Limit41.8
Readmission Rate: Lower Confidence Limit20.4

News Archive

Study to assess voluntary HIV testing, prompt treatment in South Africa, Zambia

A study in South Africa and Zambia will assess whether house-to-house voluntary HIV testing and prompt treatment of HIV infection, along with other proven HIV prevention measures, can substantially reduce the number of new HIV infections across communities.

Two immunotherapy approaches for multiple myeloma show hope

Researchers from the University of Pennsylvania's Abramson Cancer Center have developed two experimental immunotherapy methods that include one chimeric antigen receptor (CAR) T cell therapy for the treatment of multiple myeloma patients who were not responding to other treatments.

Paralympic athlete Amy Purdy to deliver opening keynote address at 41st ARN Annual Educational Conference

Registration is open for the 41st Association of Rehabilitation Nurses Annual Educational Conference on September 30-October 3, 2015, in New Orleans, which provides a forum for knowledge sharing and engagement that features the finest educators and thought leaders in the world of rehabilitation nursing.

Second Sight Medical Products receives FDA approval for Argus II Retinal Prosthesis System

The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP).

Combination of anti-Nodal and DTIC therapy can produce anti-cancer effects

Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.

Read more Medical News

› Verified 6 days ago

Infection Rate

Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Nampa Dialysis Center get infections in their blood each year compared to the number of infections expected for the center based on the national average.

Standard Infection Summary Ratio(SIR) YearJanuary, 2016 - December, 2016
Infection Rate in facility3.11 (Worse than Expected)
SIR: Upper Confidence Limit6.14
SIR: Lower Confidence Limit1.36

News Archive

Study to assess voluntary HIV testing, prompt treatment in South Africa, Zambia

A study in South Africa and Zambia will assess whether house-to-house voluntary HIV testing and prompt treatment of HIV infection, along with other proven HIV prevention measures, can substantially reduce the number of new HIV infections across communities.

Two immunotherapy approaches for multiple myeloma show hope

Researchers from the University of Pennsylvania's Abramson Cancer Center have developed two experimental immunotherapy methods that include one chimeric antigen receptor (CAR) T cell therapy for the treatment of multiple myeloma patients who were not responding to other treatments.

Paralympic athlete Amy Purdy to deliver opening keynote address at 41st ARN Annual Educational Conference

Registration is open for the 41st Association of Rehabilitation Nurses Annual Educational Conference on September 30-October 3, 2015, in New Orleans, which provides a forum for knowledge sharing and engagement that features the finest educators and thought leaders in the world of rehabilitation nursing.

Second Sight Medical Products receives FDA approval for Argus II Retinal Prosthesis System

The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP).

Combination of anti-Nodal and DTIC therapy can produce anti-cancer effects

Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.

Read more Medical News

› Verified 6 days ago

Transfusion Summary

Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Nampa Dialysis Center's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.

Standard Transfusion Summary Ratio (STrR) Year January, 2016 - December, 2016
Patients in facility's Transfusion Summary 58
Transfusion Rate in facility15.4 (As Expected)
Transfusion Rate: Upper Confidence Limit74.9
Transfusion Rate: Lower Confidence Limit3.9

News Archive

Study to assess voluntary HIV testing, prompt treatment in South Africa, Zambia

A study in South Africa and Zambia will assess whether house-to-house voluntary HIV testing and prompt treatment of HIV infection, along with other proven HIV prevention measures, can substantially reduce the number of new HIV infections across communities.

Two immunotherapy approaches for multiple myeloma show hope

Researchers from the University of Pennsylvania's Abramson Cancer Center have developed two experimental immunotherapy methods that include one chimeric antigen receptor (CAR) T cell therapy for the treatment of multiple myeloma patients who were not responding to other treatments.

Paralympic athlete Amy Purdy to deliver opening keynote address at 41st ARN Annual Educational Conference

Registration is open for the 41st Association of Rehabilitation Nurses Annual Educational Conference on September 30-October 3, 2015, in New Orleans, which provides a forum for knowledge sharing and engagement that features the finest educators and thought leaders in the world of rehabilitation nursing.

Second Sight Medical Products receives FDA approval for Argus II Retinal Prosthesis System

The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP).

Combination of anti-Nodal and DTIC therapy can produce anti-cancer effects

Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.

Read more Medical News

› Verified 6 days ago

Survival Summary

The rate of mortality show you whether patients who were being treated regularly at Nampa Dialysis Center lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.

Standard Survival Summary Ratio(SIR) YearJanuary, 2013 - December, 2016
Patients in facility's Survival Summary261
Mortality Rate in facility21.9 (As Expected)
Mortality Rate: Upper Confidence Limit30.5
Mortality Rate: Lower Confidence Limit15.3

News Archive

Study to assess voluntary HIV testing, prompt treatment in South Africa, Zambia

A study in South Africa and Zambia will assess whether house-to-house voluntary HIV testing and prompt treatment of HIV infection, along with other proven HIV prevention measures, can substantially reduce the number of new HIV infections across communities.

Two immunotherapy approaches for multiple myeloma show hope

Researchers from the University of Pennsylvania's Abramson Cancer Center have developed two experimental immunotherapy methods that include one chimeric antigen receptor (CAR) T cell therapy for the treatment of multiple myeloma patients who were not responding to other treatments.

Paralympic athlete Amy Purdy to deliver opening keynote address at 41st ARN Annual Educational Conference

Registration is open for the 41st Association of Rehabilitation Nurses Annual Educational Conference on September 30-October 3, 2015, in New Orleans, which provides a forum for knowledge sharing and engagement that features the finest educators and thought leaders in the world of rehabilitation nursing.

Second Sight Medical Products receives FDA approval for Argus II Retinal Prosthesis System

The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP).

Combination of anti-Nodal and DTIC therapy can produce anti-cancer effects

Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.

Read more Medical News

› Verified 6 days ago


Dialysis Facility in Nampa, ID

Nampa Dialysis Center
Location: 846 Parkcentre Way, Nampa, Idaho, 83651
Phone: (208) 467-5180
Liberty Dialysis - Nampa
Location: 280 West Georgia Avenue, Nampa, Idaho, 83686
Phone: (208) 463-8558

News Archive

Study to assess voluntary HIV testing, prompt treatment in South Africa, Zambia

A study in South Africa and Zambia will assess whether house-to-house voluntary HIV testing and prompt treatment of HIV infection, along with other proven HIV prevention measures, can substantially reduce the number of new HIV infections across communities.

Two immunotherapy approaches for multiple myeloma show hope

Researchers from the University of Pennsylvania's Abramson Cancer Center have developed two experimental immunotherapy methods that include one chimeric antigen receptor (CAR) T cell therapy for the treatment of multiple myeloma patients who were not responding to other treatments.

Paralympic athlete Amy Purdy to deliver opening keynote address at 41st ARN Annual Educational Conference

Registration is open for the 41st Association of Rehabilitation Nurses Annual Educational Conference on September 30-October 3, 2015, in New Orleans, which provides a forum for knowledge sharing and engagement that features the finest educators and thought leaders in the world of rehabilitation nursing.

Second Sight Medical Products receives FDA approval for Argus II Retinal Prosthesis System

The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP).

Combination of anti-Nodal and DTIC therapy can produce anti-cancer effects

Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.

Read more Medical News

› Verified 6 days ago


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.